Evidence map›Paper›PMID 25071319›Full record

ReviewWorld journal of gastroenterology2014

Cytokinome profile evaluation in patients with hepatitis C virus infection.

Francesca Capone, Eliana Guerriero, Giovanni Colonna, Patrizia Maio, Alessandra Mangia, Giuseppe Castello, Susan Costantini

Open access · greenAbstract readReview
In one paragraph

Review in World journal of gastroenterology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 28 citations in OpenAlex.

  1. Liver Macrophages in the Pathogenesis of Viral Hepatitis.Current issues in molecular biology · 2026
    Review
  2. Hostility is Associated with Interferon γ Inducible Protein 10 in Opioid Maintenance Treatment Patients with Chronic Hepatitis C.Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Francesca CaponeFrancesca Capone, Eliana Guerriero, Giuseppe Castello, Susan Costantini, Centro Ricerche Oncologiche di Mercogliano, IstitutoNazionale per lo Studio e la CuradeiTumori "Fondazione Giovanni Pascale", IRCCS, 83013 Mecogliano, Italy.
Eliana GuerrieroFrancesca Capone, Eliana Guerriero, Giuseppe Castello, Susan Costantini, Centro Ricerche Oncologiche di Mercogliano, IstitutoNazionale per lo Studio e la CuradeiTumori "Fondazione Giovanni Pascale", IRCCS, 83013 Mecogliano, Italy.
Giovanni ColonnaFrancesca Capone, Eliana Guerriero, Giuseppe Castello, Susan Costantini, Centro Ricerche Oncologiche di Mercogliano, IstitutoNazionale per lo Studio e la CuradeiTumori "Fondazione Giovanni Pascale", IRCCS, 83013 Mecogliano, Italy.
Patrizia MaioFrancesca Capone, Eliana Guerriero, Giuseppe Castello, Susan Costantini, Centro Ricerche Oncologiche di Mercogliano, IstitutoNazionale per lo Studio e la CuradeiTumori "Fondazione Giovanni Pascale", IRCCS, 83013 Mecogliano, Italy.
Alessandra MangiaFrancesca Capone, Eliana Guerriero, Giuseppe Castello, Susan Costantini, Centro Ricerche Oncologiche di Mercogliano, IstitutoNazionale per lo Studio e la CuradeiTumori "Fondazione Giovanni Pascale", IRCCS, 83013 Mecogliano, Italy.
Giuseppe CastelloFrancesca Capone, Eliana Guerriero, Giuseppe Castello, Susan Costantini, Centro Ricerche Oncologiche di Mercogliano, IstitutoNazionale per lo Studio e la CuradeiTumori "Fondazione Giovanni Pascale", IRCCS, 83013 Mecogliano, Italy.
Susan CostantiniFrancesca Capone, Eliana Guerriero, Giuseppe Castello, Susan Costantini, Centro Ricerche Oncologiche di Mercogliano, IstitutoNazionale per lo Studio e la CuradeiTumori "Fondazione Giovanni Pascale", IRCCS, 83013 Mecogliano, Italy.
Gruppo Italiano per lo Studio dei Carcinomi dell’Apparato Digerente · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The ''omics sciences'' (genomics, transcriptomics, proteomics) are often used to study living organisms as a whole system by evaluating the complex expression patterns of genes, miRNA, proteins, and metabolites. This study aimed, through bioinformatics and systems biology, to decipher the cytokinome profile in the evolution of inflammatory processes leading to cancer. The cytokinome was defined as the totality of cytokines and their interactions in and around biological cells. The system biology approach would provide a better understanding of the complex interaction network of cytokines, especially in cancer patients. Acquired knowledge would enable health providers with tools to evaluate disease onset through progression as well as identifying innovative therapeutic strategies. Understanding the role each cytokine plays in the metabolic network is of great importance. This paper reviews our group's ''omics'' work. In particular, it addresses the role cytokines play in liver disease in six different scenarios. The first is the role the cytokines play in chronic inflammatory diseases and cancers. The second is the significance of the cytokinome profile. The third is the role of liver cirrhosis as an inflammatory disease. The fourth is the comparison of cytokine levels evaluated in patients with chronic hepatitis C virus (HCV) or with HCV-related cirrhosis. The fifth is the comparison of cytokine levels evaluated in patients with HCV-related cirrhosis in the presence and absence of type 2 diabetes. And lastly, we present a comparison of cytokine levels evaluated in patients with HCV-related cirrhosis in the presence and absence of hepatocellular carcinoma.

Indexed as

ProteomicsAnimalsBiomarkersCarcinoma, HepatocellularCytokinesDiabetes Mellitus, Type 2Hepatitis C, ChronicHumansInflammation MediatorsLiver CirrhosisLiver NeoplasmsPrognosisSystems BiologyBiomarkersCytokinesInflammation MediatorsCirrhosisCytokinomeHepatitis C virusHepatocellular carcinomaInteractomeSystems biologyType 2 diabetes

Identifiers

PMID25071319
PMCPMC4110556
OpenAlexW2399201228

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.